Alexion to study ULTOMIRIS® therapy re COVID-19
Alexion Pharmaceuticals plans to initiate a global Phase 3 study to investigate ULTOMIRIS® (ravulizumab-cwvz) in a subset of adults with COVID-19 – those who are...
Home >
Access the latest news, business developments, company updates, industry trends, events and more.
Alexion Pharmaceuticals plans to initiate a global Phase 3 study to investigate ULTOMIRIS® (ravulizumab-cwvz) in a subset of adults with COVID-19 – those who are...
MDG Benefit Solutions is a nationally respected employee benefits brokerage and insurance consulting firm specializing in the implementation of insurance benefit plans and online enrollment...
Medtronic reports solid progress in the ramp-up of its ventilator production, as well as collaborating with technology partners and governments to drive new ventilator innovation and...
Intensity Therapeutics has entered into a clinical trial collaboration agreement with Bristol Myers Squibb. The program will evaluate the safety and efficacy of Intensity’s lead product...
A veteran team of Connecticut drug developers has raised $93 million for their startup, Rallybio, which is working to acquire and develop a portfolio of...
In response to the COVID-19 crisis, the Connecticut Manufacturing Innovation Fund Voucher Program will give priority and focus to manufacturers realigning or expanding capacity and...
Iqvia has a new online tool to help match interested patients diagnosed with the novel coronavirus with possible clinical trials of drugs under development to...
Pfizer has found a leading experimental drug candidate against SARS-CoV-2 and is planning to test the drug in the coming months. Pfizer’s R&D chief Mikael...
The IND was approved by the Division of Pulmonary, Allergy, and Critical Care at FDA on and Biohaven was informed that the study may proceed...
CSL Behring and SAB Biotherapeutics are partnering to combat the coronavirus pandemic with the rapid development of SAB-185, a COVID-19 therapeutic candidate on track for clinical evaluation...